Ulcerative Colitis Study
We are conducting a research study to learn more about the safety & tolerability of KB295 in people with Ulcerative Colitis (UC).
- Be aged between 18-75 years old
- Have a BMI of between 18.5-45.0
- Have experienced mild to moderate symptoms of Ulcerative Colitis over the past 4 weeks
Please complete the Pre-Screening Questionnaire to help us determine your eligibility for the trial.